Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator

Irene Paterniti, Emanuela Mazzon, Esposito Emanuela, Rosanna D. Paola, Maria Galuppo, Placido Bramanti, Salvatore Cuzzocrea

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The standard iron-chelator deferoxamine is known to reduce neurological deficits. The aim of the present study was to evaluate the contribution of deferoxamine in the secondary damage in experimental spinal cord injury (SCI) in mice, induced by the application of vascular clips to the dura via a four-level T5T8 laminectomy. SCI resulted in production of inflammatory mediators, tissue damage and apoptosis. Deferoxamine treatment 30 min before and 1 and 6 h after the SCI significantly reduced: (1) GFAP immunoreactivity, (2) neutrophil infiltration, (3) NF-κB activation, (4) iNOS expression, (5) nitrotyrosine and MDA formation, (6) DNA damage (methyl green pyronin staining and PAR formation and (7) apoptosis (TUNEL staining, FasL, Bax and Bcl-2 expression, S-100 expression). Moreover, deferoxamine significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, the results clearly demonstrate that deferoxamine treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.

Original languageEnglish
Pages (from-to)694-709
Number of pages16
JournalFree Radical Research
Volume44
Issue number6
DOIs
Publication statusPublished - 2010

Fingerprint

Deferoxamine
Chelating Agents
Spinal Cord Injuries
Iron
Modulation
Tissue
Apoptosis
Staining and Labeling
Methyl Green
Recovery
Laminectomy
Neutrophil Infiltration
Recovery of Function
In Situ Nick-End Labeling
Infiltration
Surgical Instruments
DNA Damage
Blood Vessels
Extremities
Chemical activation

Keywords

  • Apoptosis
  • Inflammatory mediators
  • SCI
  • Tissue damage

ASJC Scopus subject areas

  • Biochemistry

Cite this

Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator. / Paterniti, Irene; Mazzon, Emanuela; Emanuela, Esposito; Paola, Rosanna D.; Galuppo, Maria; Bramanti, Placido; Cuzzocrea, Salvatore.

In: Free Radical Research, Vol. 44, No. 6, 2010, p. 694-709.

Research output: Contribution to journalArticle

Paterniti, Irene ; Mazzon, Emanuela ; Emanuela, Esposito ; Paola, Rosanna D. ; Galuppo, Maria ; Bramanti, Placido ; Cuzzocrea, Salvatore. / Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator. In: Free Radical Research. 2010 ; Vol. 44, No. 6. pp. 694-709.
@article{2e1a73258cfe4306bff3318dde554c3f,
title = "Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator",
abstract = "The standard iron-chelator deferoxamine is known to reduce neurological deficits. The aim of the present study was to evaluate the contribution of deferoxamine in the secondary damage in experimental spinal cord injury (SCI) in mice, induced by the application of vascular clips to the dura via a four-level T5T8 laminectomy. SCI resulted in production of inflammatory mediators, tissue damage and apoptosis. Deferoxamine treatment 30 min before and 1 and 6 h after the SCI significantly reduced: (1) GFAP immunoreactivity, (2) neutrophil infiltration, (3) NF-κB activation, (4) iNOS expression, (5) nitrotyrosine and MDA formation, (6) DNA damage (methyl green pyronin staining and PAR formation and (7) apoptosis (TUNEL staining, FasL, Bax and Bcl-2 expression, S-100 expression). Moreover, deferoxamine significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, the results clearly demonstrate that deferoxamine treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.",
keywords = "Apoptosis, Inflammatory mediators, SCI, Tissue damage",
author = "Irene Paterniti and Emanuela Mazzon and Esposito Emanuela and Paola, {Rosanna D.} and Maria Galuppo and Placido Bramanti and Salvatore Cuzzocrea",
year = "2010",
doi = "10.3109/10715761003742993",
language = "English",
volume = "44",
pages = "694--709",
journal = "Free Radical Research",
issn = "1071-5762",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator

AU - Paterniti, Irene

AU - Mazzon, Emanuela

AU - Emanuela, Esposito

AU - Paola, Rosanna D.

AU - Galuppo, Maria

AU - Bramanti, Placido

AU - Cuzzocrea, Salvatore

PY - 2010

Y1 - 2010

N2 - The standard iron-chelator deferoxamine is known to reduce neurological deficits. The aim of the present study was to evaluate the contribution of deferoxamine in the secondary damage in experimental spinal cord injury (SCI) in mice, induced by the application of vascular clips to the dura via a four-level T5T8 laminectomy. SCI resulted in production of inflammatory mediators, tissue damage and apoptosis. Deferoxamine treatment 30 min before and 1 and 6 h after the SCI significantly reduced: (1) GFAP immunoreactivity, (2) neutrophil infiltration, (3) NF-κB activation, (4) iNOS expression, (5) nitrotyrosine and MDA formation, (6) DNA damage (methyl green pyronin staining and PAR formation and (7) apoptosis (TUNEL staining, FasL, Bax and Bcl-2 expression, S-100 expression). Moreover, deferoxamine significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, the results clearly demonstrate that deferoxamine treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.

AB - The standard iron-chelator deferoxamine is known to reduce neurological deficits. The aim of the present study was to evaluate the contribution of deferoxamine in the secondary damage in experimental spinal cord injury (SCI) in mice, induced by the application of vascular clips to the dura via a four-level T5T8 laminectomy. SCI resulted in production of inflammatory mediators, tissue damage and apoptosis. Deferoxamine treatment 30 min before and 1 and 6 h after the SCI significantly reduced: (1) GFAP immunoreactivity, (2) neutrophil infiltration, (3) NF-κB activation, (4) iNOS expression, (5) nitrotyrosine and MDA formation, (6) DNA damage (methyl green pyronin staining and PAR formation and (7) apoptosis (TUNEL staining, FasL, Bax and Bcl-2 expression, S-100 expression). Moreover, deferoxamine significantly ameliorated the recovery of limb function (evaluated by motor recovery score). Taken together, the results clearly demonstrate that deferoxamine treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.

KW - Apoptosis

KW - Inflammatory mediators

KW - SCI

KW - Tissue damage

UR - http://www.scopus.com/inward/record.url?scp=77953604105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953604105&partnerID=8YFLogxK

U2 - 10.3109/10715761003742993

DO - 10.3109/10715761003742993

M3 - Article

VL - 44

SP - 694

EP - 709

JO - Free Radical Research

JF - Free Radical Research

SN - 1071-5762

IS - 6

ER -